Hospital ancillary software vendor Omnicell Inc. is significantly enhancing its focus on medication management with the acquisition of MTS Medication Technologies Inc. of St. Petersburg, Fla.
Under terms of the acquisition, Mountain View, Calif.-based Omnicell will pay approximately $156 million in cash, more than double the $75 million in revenue MTS had in its last fiscal year ending March 31, 2012. For the year, MTS had adjusted earnings of $12 million, and Omnicell expects the buy will add to its earnings immediately.
Register or login for access to this item and much more
All Health Data Management content is archived after seven days.
Community members receive:
- All recent and archived articles
- Conference offers and updates
- A full menu of enewsletter options
- Web seminars, white papers, ebooks
Already have an account? Log In
Don't have an account? Register for Free Unlimited Access